HLS Therapeutics Overview
- Year Founded
-
2014
- Status
-
Public
- Employees
-
86
- Stock Symbol
-
HLS
- Investments
-
1
- Share Price
-
$2.54
- (As of Friday Closing)
HLS Therapeutics General Information
Description
HLS Therapeutics Inc is a specialty pharmaceutical company. It is focused on the acquisition and commercialization of branded pharmaceutical products in the North American markets. The company's products include Clozaril, Vascepa, CSAN Pronto, and others. The company earns revenue in the form of product sales and royalties, out of which product sales contribute to the majority of the revenue. The company operates in Canada, the United States, and the Rest of world, with the majority of its revenue generated from Canada.
Contact Information
Website
www.hlstherapeutics.comCorporate Office
- 10 Carlson Court
- Suite 701
- Etobicoke, Ontario M9W 6L2
- Canada
Corporate Office
- 10 Carlson Court
- Suite 701
- Etobicoke, Ontario M9W 6L2
- Canada
HLS Therapeutics Stock Performance
As of 20-Nov-2026, HLS Therapeutics’s stock price is $2.54. Its current market cap is $78.7M with 30.9M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $2.54 | $2.56 | $2.46 - $3.75 | $78.7M | 30.9M | 66.1K | -$0.22 |
HLS Therapeutics Financials Summary
As of 30-Sep-2026, HLS Therapeutics has a trailing 12-month revenue of $56.9M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 119,759 | 154,069 | 135,145 | 166,531 |
| Revenue | 56,887 | 55,500 | 56,619 | 63,074 |
| EBITDA | 17,640 | 15,928 | 16,899 | 12,534 |
| Net Income | (6,878) | (12,430) | (19,655) | (27,531) |
| Total Assets | 120,768 | 137,529 | 159,904 | 209,060 |
| Total Debt | 41,025 | 49,822 | 66,450 | 87,621 |
HLS Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
HLS Therapeutics Comparisons
Industry
Financing
Details
HLS Therapeutics Competitors (11)
One of HLS Therapeutics’s 11 competitors is ANI Pharmaceuticals, a Corporation company based in Baudette, MN.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| ANI Pharmaceuticals | Corporation | Baudette, MN | ||||
| Apotex Health | Formerly PE-Backed | Toronto, Canada | ||||
| GSK | Corporation | London, United Kingdom | ||||
| Teva Pharmaceutical Industries | Corporation | Tel Aviv, Israel | ||||
| Novartis | Corporation | Basel, Switzerland |
HLS Therapeutics Signals
HLS Therapeutics Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
HLS Therapeutics Acquisitions (1)
HLS Therapeutics’s most recent deal was a Merger/Acquisition with Automodular for . The deal was made on 12-Mar-2018.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Automodular | 12-Mar-2018 | Merger/Acquisition | Holding Companies |
HLS Therapeutics ESG
Risk Overview
Risk Rating
Updated April, 30, 2022
44.42 | Severe Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 15,669
Rank
Percentile
Pharmaceuticals
Industry
of 895
Rank
Percentile
Pharmaceuticals
Subindustry
of 431
Rank
Percentile
HLS Therapeutics FAQs
-
When was HLS Therapeutics founded?
HLS Therapeutics was founded in 2014.
-
Where is HLS Therapeutics headquartered?
HLS Therapeutics is headquartered in Etobicoke, Canada.
-
What is the size of HLS Therapeutics?
HLS Therapeutics has 86 total employees.
-
What industry is HLS Therapeutics in?
HLS Therapeutics’s primary industry is Pharmaceuticals.
-
Is HLS Therapeutics a private or public company?
HLS Therapeutics is a Public company.
-
What is HLS Therapeutics’s stock symbol?
The ticker symbol for HLS Therapeutics is HLS.
-
What is the current stock price of HLS Therapeutics?
As of 20-Nov-2026 the stock price of HLS Therapeutics is $2.54.
-
What is the current market cap of HLS Therapeutics?
The current market capitalization of HLS Therapeutics is $78.7M.
-
What is HLS Therapeutics’s current revenue?
The trailing twelve month revenue for HLS Therapeutics is $56.9M.
-
Who are HLS Therapeutics’s competitors?
ANI Pharmaceuticals, Apotex Health, GSK, Teva Pharmaceutical Industries, and Novartis are some of the 11 competitors of HLS Therapeutics.
-
What is HLS Therapeutics’s annual earnings per share (EPS)?
HLS Therapeutics’s EPS for 12 months was -$0.22.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process